FRANCISCO JAVIER
GOMEZ-ULLA DE IRAZAZABAL
Investigador no período 1984-2019
![Foto de José María](/img/nophoto.png)
José María
Ruiz Moreno
Publicacións nas que colabora con José María Ruiz Moreno (16)
2015
-
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Journal of Ophthalmology, Vol. 2015
-
Patología retiniana en alta miopía
Sociedad Española de Oftalmología (SEO)
-
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
Drugs and Aging, Vol. 32, Núm. 10, pp. 797-807
2014
-
A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration
Journal of Ophthalmology, Vol. 2014
2013
-
Photodynamic therapy for chronic central serous chorioretinopathy: A 4-year follow-up study
Retina, Vol. 33, Núm. 2, pp. 309-315
2012
2011
-
Myopic choroidal neovascularization
Ophthalmology
2010
-
Photodynamic therapy for chronic central serous chorioretinopathy
Acta Ophthalmologica, Vol. 88, Núm. 3, pp. 371-376
-
Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization
Retina, Vol. 30, Núm. 10, pp. 1609-1615
2009
-
A 1-year retrospective review of ranibizumab for naïve nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration
Retina, Vol. 29, Núm. 10, pp. 1444-1449
-
Efficacy of intravitreal bevacizumab to treat retinal angiomatous proliferation stage II and III
European Journal of Ophthalmology, Vol. 19, Núm. 3, pp. 448-451
-
Guías de práctica clínica de la SERV: Tratamiento de la degeneración macular asociada a la edad (DMAE) exudativa
Archivos de la Sociedad Española de Oftalmologia, Vol. 84, Núm. 7, pp. 333-344
-
Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome
British Journal of Ophthalmology, Vol. 93, Núm. 4, pp. 448-451
-
Intravitreous bevacizumab to treat subfoveal choroidal neovascularization in highly myopic eyes: Short-term results
Eye, Vol. 23, Núm. 2, pp. 334-338
-
Photodynamic therapy may worsen the prognosis of highly myopic choroidal neovascularisation treated by intravitreal bevacizumab
British Journal of Ophthalmology
2006
-
Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization
Acta Ophthalmologica Scandinavica, Vol. 84, Núm. 6, pp. 743-748